Evidence map›Paper›PMID 31571712›Full record

Trial reportIndian journal of pharmacology

Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.

Ganesh N Dakhale, Vikas Sohanlal Sharma, Manish N Thakre, Mrunalini Kalikar

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Advancements in Valproate Therapy for Seizures, Migraines, and Bipolar Disorders.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ganesh N DakhaleDepartment of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
Vikas Sohanlal SharmaDepartment of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.
Manish N ThakreDepartment of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
Mrunalini KalikarDepartment of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
Government Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextMigraine is the second most common headache disorder. However, prophylactic therapy remains underutilized.

aimsThe objective of the study was to compare the efficacy and safety of low-dose sodium valproate and low-dose propranolol sustained release (SR) in the prophylaxis of common migraine headache. SETTINGS AND

designThe study was conducted in a tertiary care teaching institute. It was a randomized, prospective, parallel, open-label, clinical study. SUBJECTS AND

methodsThe study included 60 patients with common migraine headaches (≥2 attacks/month) treated for 12 weeks. The patients were randomly divided into two treatment groups treated by sodium valproate 500 mg/day and propranolol SR 40 mg/day, respectively. The primary outcome measures were the percentage of responders (i.e., >50% decrease in mean headache frequency) at the end of 12 weeks and decrease in mean headache frequency (per 4 weeks) at the end of 12 weeks. The patients were assessed at 0, 4, 8, and 12 weeks of the study. STATISTICAL ANALYSIS USED: Intention-to-treat analysis was used for all the statistical analysis.

resultsFifty-five patients completed the study. At the end of the treatment, both sodium valproate and propranolol caused a significant (

conclusionBoth sodium valproate and propranolol significantly reduced frequency, severity, and duration of migraine headache, but propranolol caused significantly greater reduction in the severity of headache compared to sodium valproate. Both the medications were well tolerated and did not result in discontinuation.

Indexed as

Adrenergic beta-AntagonistsAdultAnticonvulsantsFemaleHumansMaleMiddle AgedMigraine DisordersPropranololSeverity of Illness IndexTreatment OutcomeValproic AcidVasodilator AgentsYoung AdultAdrenergic beta-AntagonistsAnticonvulsantsPropranololValproic AcidVasodilator AgentsLow dosemigraine headachepropranololsodium valproate

Identifiers

PMID31571712
PMCPMC6759533
OpenAlexW2973166613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.